home / stock / ljpc / ljpc quote
Last: | $6.22 |
---|---|
Change Percent: | 0.0% |
Open: | $6.21 |
Close: | $6.22 |
High: | $6.24 |
Low: | $6.2 |
Volume: | 267,682 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.22 | $6.21 | $6.22 | $6.24 | $6.2 | 267,682 | 08-19-2022 |
$6.22 | $6.18 | $6.22 | $6.22 | $6.16 | 341,015 | 08-18-2022 |
$6.17 | $6.19 | $6.17 | $6.205 | $5.82 | 1,482,763 | 08-17-2022 |
$6.2 | $6.21 | $6.2 | $6.22 | $6.19 | 1,771,251 | 08-16-2022 |
$6.19 | $6.2 | $6.19 | $6.22 | $6.19 | 960,928 | 08-15-2022 |
$6.21 | $6.2 | $6.21 | $6.21 | $6.2 | 62,430 | 08-12-2022 |
$6.2 | $6.21 | $6.2 | $6.21 | $6.2 | 56,890 | 08-11-2022 |
$6.2 | $6.2 | $6.2 | $6.21 | $6.2 | 82,292 | 08-10-2022 |
$6.2 | $6.2 | $6.2 | $6.21 | $6.2 | 92,682 | 08-09-2022 |
$6.2 | $6.2 | $6.2 | $6.21 | $6.2 | 156,992 | 08-08-2022 |
$6.2 | $6.2 | $6.2 | $6.21 | $6.2 | 73,611 | 08-05-2022 |
$6.2 | $6.21 | $6.2 | $6.22 | $6.2 | 97,971 | 08-04-2022 |
$6.22 | $6.21 | $6.22 | $6.22 | $6.21 | 111,342 | 08-03-2022 |
$6.21 | $6.2 | $6.21 | $6.22 | $6.2 | 140,991 | 08-02-2022 |
$6.2 | $6.19 | $6.2 | $6.21 | $6.19 | 245,424 | 08-01-2022 |
$6.21 | $6.2 | $6.21 | $6.22 | $6.19 | 134,759 | 07-29-2022 |
$6.2 | $6.19 | $6.2 | $6.21 | $6.19 | 121,376 | 07-28-2022 |
$6.2 | $6.2 | $6.2 | $6.22 | $6.19 | 139,196 | 07-26-2022 |
$6.19 | $6.2 | $6.19 | $6.2 | $6.18 | 207,777 | 07-19-2022 |
$6.19 | $6.17 | $6.19 | $6.2 | $6.16 | 244,073 | 07-18-2022 |
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...